BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200929T120000
DTEND;TZID=America/Vancouver:20200929T130000
DTSTAMP:20260810T220236
CREATED:20200915T164205Z
LAST-MODIFIED:20200915T164205Z
UID:10669-1601380800-1601384400@scienceinboston.com
SUMMARY:PROTACs - Targeted Protein Degradation: Promises And Challenges Ahead
DESCRIPTION:Targeted protein degradation is an emerging therapeutic modality which has made tremendous progress and attracted massive investment in recent years. This modality is a class of bifunctional small molecules composed of an E3 ligase binder linked to a target protein binding moiety. It offers the possibility to degrade any intracellular target proteins regardless if there is a well-defined binding pocket in the target protein. Therefore\, it opens numerous opportunities to drug many previously unreachable targets. However\, the molecules tend to be bulky\, floppy\, greasy\, and lack drug likeness properties. Nevertheless\, increasing preclinical animal data has demonstrated the desired efficacy. Very recently\, the early clinical safety and PK results are encouraging. In this forum our expert panel will share key learnings about this novel modality and discuss strategies to overcome potential challenges ahead. \nSponsored by MassBio’s Drug Discovery forum working group. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/protacs-targeted-protein-degradation-promises-and-challenges-ahead/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200929T120000
DTEND;TZID=America/Vancouver:20200929T130000
DTSTAMP:20260810T220236
CREATED:20200915T164205Z
LAST-MODIFIED:20200915T164205Z
UID:27579-1601380800-1601384400@scienceinboston.com
SUMMARY:PROTACs - Targeted Protein Degradation: Promises And Challenges Ahead
DESCRIPTION:Targeted protein degradation is an emerging therapeutic modality which has made tremendous progress and attracted massive investment in recent years. This modality is a class of bifunctional small molecules composed of an E3 ligase binder linked to a target protein binding moiety. It offers the possibility to degrade any intracellular target proteins regardless if there is a well-defined binding pocket in the target protein. Therefore\, it opens numerous opportunities to drug many previously unreachable targets. However\, the molecules tend to be bulky\, floppy\, greasy\, and lack drug likeness properties. Nevertheless\, increasing preclinical animal data has demonstrated the desired efficacy. Very recently\, the early clinical safety and PK results are encouraging. In this forum our expert panel will share key learnings about this novel modality and discuss strategies to overcome potential challenges ahead. \nSponsored by MassBio’s Drug Discovery forum working group. \nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/protacs-targeted-protein-degradation-promises-and-challenges-ahead-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR